Endpoint
Pulse wave velocity (segment unspecified)
Evaluation of the contour of the pulse waves which vary in different parts of the circulation and depend on physiological as well as pathophysiological conditions of the individual.
CAT:outcome/pulse-wave-velocity-unspecified-segmentreported in m/s1 finding from 1 compound
What moved it
How to read these marks1 finding · 1 compound · by evidence strength
| Compound | Direction | Findings | Strongest evidence |
|---|---|---|---|
| curcumin | down | 1 | Evidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence. |
Reported to move it
1 finding
curcumin — decreases
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Our results showed that curcumin intervention significantly reduced pulse wave velocity, increased level of serum adiponectin and decreased level of leptin.”
Quoted verbatim from Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial.. - Study
- RCT
- Duration
- 6 months
- Population
- adults with type 2 diabetes
Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial.2014PMID:24445038Permalink
How it is measured
Arterial pulse wave velocity computed as the distance between two arterial recording sites divided by the pulse transit time between them, where the source report does not state which arterial segment was interrogated or which device was used.
Sources cited
1 paper
- Subject
- pulse wave velocity (segment unspecified)
- Findings
- 1
- Papers
- 1